ARTICLE | Clinical News
Ronacaleret: Phase II discontinued
September 29, 2008 7:00 AM UTC
NPS disclosed in an SEC filing that GSK terminated a 12-month Phase II trial of oral ronacaleret (SB-751689) to treat osteoporosis in postmenopausal women. In a letter to study investigators, GSK said...